A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19 − 9 (CA19-9) is limited. Therefore, this study aims to identify novel tumor-associated autoantibodies...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2023-11-01
|
| Seri Bilgileri: | Cancer Cell International |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12935-023-03107-1 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|